Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MOUNTAIN VIEW, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ:VVUS) today announced that it will provide an update and report financial results for the third quarter ended September 30,...
-
MOUNTAIN VIEW, Calif., July 23, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ:VVUS) today announced that it will provide an update and report financial results for the second quarter ended June 30,...
-
MOUNTAIN VIEW, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will provide an update and report financial results for the first quarter ended March 31,...
-
MOUNTAIN VIEW, Calif., Feb. 19, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the fourth quarter and year ended December 31, 2014 after...
-
MOUNTAIN VIEW, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the third quarter ended September 30, 2014 after the NASDAQ...
-
MOUNTAIN VIEW, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) today announced that it will report financial results for the second quarter ended June 30, 2014 after the NASDAQ...
-
MOUNTAIN VIEW, Calif., April 29, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the first quarter ended March 31, 2014 after the NASDAQ...
-
MOUNTAIN VIEW, Calif., Feb. 24, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV...
-
MOUNTAIN VIEW, Calif., Feb. 19, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the fourth quarter and year ended December 31, 2013 after...
-
MOUNTAIN VIEW, Calif. and CHESTERBROOK, Pa., Jan. 21, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) and Auxilium Pharmaceuticals, Inc. (Nasdaq:AUXL) today announced that the U.S. Food and Drug...